These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32760098)

  • 1. Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    Byeon HJ; Kim JY; Ko J; Lee EJ; Don K; Yoon JS
    PLoS One; 2020; 15(8):e0237015. PubMed ID: 32760098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis.
    Ko J; Kim JY; Kyoung Chae M; Jig Lee E; Sook Yoon J
    J Mol Endocrinol; 2021 May; 66(4):313-323. PubMed ID: 33870911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy.
    Ko J; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2544-2553. PubMed ID: 28492873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
    Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.
    Lee JS; Kim J; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4129-4140. PubMed ID: 31593984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of binding immunoglobulin protein (BiP) in Graves' orbitopathy pathogenesis.
    Ko J; Kim JY; Lee EJ; Yoon JS
    J Mol Endocrinol; 2021 Jan; 66(1):71-81. PubMed ID: 33112798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
    Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
    Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
    Park HY; Chae MK; Ko J; Kikkawa DO; Jang SY; Yoon JS
    PLoS One; 2022; 17(12):e0279060. PubMed ID: 36521376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-like weak inducer of apoptosis induces inflammation in Graves' orbital fibroblasts.
    Lee SJ; Kim J; Ko J; Lee EJ; Koh HJ; Yoon JS
    PLoS One; 2018; 13(12):e0209583. PubMed ID: 30576385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
    Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
    Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
    [No Abstract]   [Full Text] [Related]  

  • 13. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
    Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    Jang SY; Choi SH; Kikkawa D; Lee EJ; Yoon JS
    PLoS One; 2021; 16(8):e0255344. PubMed ID: 34383782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
    Ko J; Kim JY; Kim JW; Yoon JS
    Endocr J; 2020 Apr; 67(4):439-447. PubMed ID: 31941844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
    Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Inositol-Requiring Enzyme 1 and Autophagy in the Pro-Fibrotic Mechanism Underlying Graves' Orbitopathy.
    Lee CE; Kim JY; Yoon JS; Ko J
    Yonsei Med J; 2024 Jul; 65(7):397-405. PubMed ID: 38910302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
    Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
    Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy.
    Yoon JS; Chae MK; Jang SY; Lee SY; Lee EJ
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5921-9. PubMed ID: 22871832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic role of histone deacetylase inhibition in an
    Byeon HJ; Choi SH; Kikkawa DO; Ko J; Yoon JS
    Mol Med Rep; 2024 Dec; 30(6):. PubMed ID: 39329199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.